3-噁唑-2-苯胺 | 35582-08-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 3-噁唑-2-苯胺
• 中文别名: 3-(恶唑-2-基)苯胺
• 英文名称: 3-(oxazol-2-yl)aniline
• 英文别名: 2-(m-Amino-Phenyl)-Oxazol；2-(3-aminophenyl)1,3-oxazole；3-(1,3-Oxazol-2-yl)aniline
• CAS: 35582-08-2
• 化学式: C₉H₈N₂O
• 分子量: 160.175
• InChiKey: PMLOUCFXSMIGQI-UHFFFAOYSA-N

物化性质

• 熔点：
  69-70 °C
• 沸点：
  344.1±44.0 °C(Predicted)
• 密度：
  1.204±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  52
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2934999090

反应信息

• 作为反应物：
  描述：

  3-噁唑-2-苯胺 生成 2-(3-chlorophenyl)oxazole
  参考文献：
  名称：

  The Pomeranz-Fritsch reaction, isoquinoline vs. oxazoles

  摘要：

  DOI：

  10.1021/jo00439a025
• 作为产物：
  描述：

  2-(3-硝基苯基)恶唑 在 铁粉 、 氯化铵 作用下， 以 乙醇 、 水 为溶剂， 反应 2.0h， 生成 3-噁唑-2-苯胺
  参考文献：
  名称：

  [EN] HEPARAN SULFATE BIOSYNTHESIS INHIBITORS FOR THE TREATMENT OF DISEASES
  [FR] INHIBITEURS DE BIOSYNTHÈSE D'HÉPARANE SULFATE POUR TRAITER DES MALADIES

  摘要：

  公开号：

  WO2016057834A9

文献信息

• [EN] 5-SULFAMOYL-2-HYDROXYBENZAMIDE DERIVATIVES<br/>[FR] DÉRIVÉS DE 5-SULFAMOYL-2-HYDROXYBENZAMIDE
  申请人：GLAXOSMITHKLINE IP DEV LTD

  公开号：WO2017153952A1

  公开（公告）日：2017-09-14

  The invention is directed to substituted salicylamide derivatives. Specifically, the invention is directed to compounds according to Formula (I): wherein R, R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof. The compounds of the invention are inhibitors of CD73 and can be useful in the treatment of cancer, pre-cancerous syndromes and diseases associated with CD73 inhibition, such as AIDS, the treatment of HIV, autoimmune diseases, infections, atherosclerosis, and ischemia–reperfusion injury. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting CD73 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

  本发明涉及取代水杨酰胺衍生物。具体而言，本发明涉及根据公式(I)的化合物：其中R、R1和R2如本文所述，或其药用可接受的盐。本发明的化合物是CD73的抑制剂，可用于治疗癌症、前癌症综合症以及与CD73抑制相关的疾病，例如艾滋病、治疗HIV、自身免疫疾病、感染、动脉粥样硬化和缺血再灌注损伤。因此，本发明进一步涉及包含本发明化合物的药物组合物。本发明还进一步涉及使用本发明化合物或包含本发明化合物的药物组合物来抑制CD73活性和治疗与之相关的疾病的方法。
• Aryl urea (thiourea) and cyanoguanidine derivatives
  申请人：E. R. Squibb & Sons, Inc.

  公开号：US05374643A1

  公开（公告）日：1994-12-20

  Novel compounds useful, for example, in the treatment of ischemic conditions and arrhythmia having the formula I ##STR1## wherein X is oxygen, sulfur or --NCN and the R groups are as defined herein.

  新型化合物具有以下公式I，其中X为氧、硫或--NCN，R基固定如定义。这些化合物可用于治疗缺血症和心律失常等疾病。
• [EN] NOVEL KINASE INHIBITORS<br/>[FR] NOUVEAUX INHIBITEURS DE KINASES
  申请人：ORIGENIS GMBH

  公开号：WO2014060113A1

  公开（公告）日：2014-04-24

  The present invention relates to novel compounds of formula (I) that are capable of inhibiting one or more kinases, especially SYK (Spleen Tyrosine Kinase), LRRK2 (Leucine-rich repeat kinase 2) and/or MYLK (Myosin light chain kinase) or mutants thereof. The compounds find applications in the treatment of a variety of diseases. These diseases include autoimmune diseases, inflammatory diseases, bone diseases, metabolic diseases, neurological and neurodegenerative diseases, cancer, cardiovascular diseases, allergies, asthma, alzheimer's disease, parkinson's disease, skin disorders, eye diseases, infectious diseases and hormone-related diseases.

  本发明涉及一种具有公式（I）的新化合物，能够抑制一个或多个激酶，特别是SYK（脾酪氨酸激酶）、LRRK2（富含亮氨酸重复的激酶2）和/或MYLK（肌球蛋白轻链激酶）或其突变体。这些化合物在治疗多种疾病中发挥作用。这些疾病包括自身免疫疾病、炎症性疾病、骨疾病、代谢性疾病、神经和神经退行性疾病、癌症、心血管疾病、过敏、哮喘、阿尔茨海默病、帕金森病、皮肤疾病、眼部疾病、传染病和激素相关疾病。
• Method for treating neoplasia with amino or pyridylamino cyclobutene derivatives
  申请人：Cell Pathways, Inc.

  公开号：US06211220B1

  公开（公告）日：2001-04-03

  A method for inhibiting neoplasia, particularly cancerous and precancerous lesions by exposing the affected cells to amino or pyridylamino cyclobutane derivatives.

  通过将受影响的细胞暴露于氨基或吡啶基氨基环丁烷衍生物，抑制肿瘤，尤其是癌症和癌前病变的方法。
• Synthesis of pyrimido[4,5-b]indoles and benzo[4,5]furo[2,3-d]pyrimidines via palladium-catalyzed intramolecular arylation
  作者：Yue-Mei Zhang、Thomas Razler、Paul F. Jackson

  DOI：10.1016/s0040-4039(02)02036-1

  日期：2002.11

  Various pyrimido[4,5-b]indoles and benzo[4,5]furo[2,3-d]pyrimidines were synthesized via a palladium-catalyzed intramolecular arylation of pyrimidine substrates. Thus, 4-aryloxy- or 4-anilino-5-iodopyrimidines were treated with Pd(OAc)2(PPh3)2 and base in DMF to give the regioselective cyclized heterocycles.

  通过嘧啶底物的钯催化分子内芳基化反应合成了各种嘧啶并[4,5- b ]吲哚和苯并[4,5]呋喃[2,3- d ]嘧啶。因此，用Pd（OAc）2（PPh 3）2和在DMF中的碱处理4-芳氧基-或4-苯胺基-5-碘嘧啶，得到区域选择性环化的杂环。